Anticardiolipin and anti‐beta 2‐glycoprotein I antibodies in patients with unexplained articular manifestations
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24812
Abstract: To determine the frequency of antiphospholipid antibodies (aPL) in patients with unexplained articular manifestations. read more here.
Keywords: articular manifestations; unexplained articular; anticardiolipin anti; patients unexplained ... See more keywords
Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset
Sign Up to like & getrecommendations! Published in 2021 at "Lupus"
DOI: 10.1177/09612033211014248
Abstract: Objective Anti-beta 2 glycoprotein I IgA is a common isotype of anti-beta 2 glycoprotein I in SLE. Anti-beta 2 glycoprotein I was not included in the American College of Rheumatology (ACR) SLE classification criteria, but… read more here.
Keywords: anti beta; glycoprotein iga; beta glycoprotein;
A systematic review of the association between anti-beta-2 glycoprotein I antibodies and APS manifestations.
Sign Up to like & getrecommendations! Published in 2021 at "Blood advances"
DOI: 10.1182/bloodadvances.2021005205
Abstract: Anti-beta-2 glycoprotein I antibodies (anti-B2GPI) are often cited as the major pathogenically relevant antibody in antiphospholipid syndrome (APS), but it is unclear if there is clinical evidence to support this theory. We performed a systematic… read more here.
Keywords: systematic review; beta glycoprotein; association; anti b2gpi ... See more keywords